We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA

    Objectives

    Studies showed angiotensin II type 2 receptor/angiotensin II type 4 receptor (AT2R/AT4R) stimulatory antihypertensive was associated with a...

    Eissa Jafari, Sumaya Abuloha, ... Hui Shao in Journal of Racial and Ethnic Health Disparities
    Article 18 March 2024
  2. Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy

    This Korean nationwide, multicenter, noninterventional, prospective cohort study aimed to analyze physician adherence to guideline-recommended...

    In-Cheol Kim, Jong-Chan Youn, ... Dong Ryeol Ryu in Scientific Reports
    Article Open access 11 May 2022
  3. Renin-Angiotensin System and Cancer: From Laboratory to Clinics

    Renin-Angiotensin System (RAS) is a vital system regulating blood pressure and maintaining sodium homeostasis in the human body. It consists of...
    Chapter 2023
  4. Renin Angiotensin System Inhibitors in Heart Failure with Reduced Ejection Fraction: Clinical Evidence and Considerations for Use

    The renin angiotensin systemRenin angiotensin system (RAS) plays an important role in the regulation of body fluids and blood pressure. Therapy with...
    Sigurd Hartnett, Buddhadeb Dawn in The Renin Angiotensin System in Cardiovascular Disease
    Chapter 2023
  5. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

    Background

    In patients with acute coronary syndrome (ACS), angiotensin-converting enzyme (ACE) inhibitors are preferred over angiotensin receptor...

    Maximilian Tscharre, Patricia P. Wadowski, ... Thomas Gremmel in Cardiovascular Drugs and Therapy
    Article Open access 18 December 2020
  6. Renin Angiotensin System Activity in Different Cancers: Mechanistic Insight and Preclinical Studies

    The Renin Angiotensin System (RAS) is maintain arterial blood pressure as well as fluid and electrolyte balance in human body. In recent there...
    Chapter 2023
  7. Preventing Progression of Chronic Kidney Disease: Renin–Angiotensin–Aldosterone System Blockade Beyond Blood Pressure

    There is clear evidence for the pathogenic role of the renin–angiotensin–aldosterone system (RAAS) in the development and progression of CKD....
    Chapter 2023
  8. Use of Angiotensin II Receptor Blockers, Angiotensin I-Converting Enzyme Polymorphism and Associations with Memory Performance in Older People

    Abstract

    We explored the relationships between the use of Angiotensin II receptor blockers (ARBs), Angiotensin I-converting enzyme (ACE) genetic...

    T. J. Oscanoa, E. C. Cieza, ... R. Romero-Ortuno in Advances in Gerontology
    Article 01 April 2021
  9. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation

    Insulin resistance is a major contributor to the pathogenesis of several human diseases, including type 2 diabetes, hypertension, and hyperlipidemia....

    ** Wook Lee, Hyun-Oh Gu, ... Byung-Chul Oh in Experimental & Molecular Medicine
    Article Open access 01 May 2023
  10. Renin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis

    Background

    Hypertension is a recognized risk factor for Parkinson’s disease (PD). The renin-angiotensin system (RAS) inhibitors are widely used to...

    Tian-xiang Xu, Hai-yin Jiang, Zeng-yan Yang in Acta Neurologica Belgica
    Article Open access 26 April 2024
  11. Renin-Angiotensin-Aldosterone System Role in Organ Fibrosis

    The normal healing process secondary to injury, disease or toxins is a mandatory process to human life. The healing process begins with hemostasis,...
    Maha Ghanem, Haidy Moustafa Abdelsalam Megahed in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  12. Implications of Renin-Angiotensin System in Health and Disease

    The renin-angiotensin system (RAS) is one of major neuro-endocrine entity which is intimately involved in regulating the cellular functions and...
    Anureet K. Shah, Sushma Yadav, Hoda Yeganehjoo in The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases
    Chapter 2023
  13. Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists

    Heart failure is a significant public health concern characterized by notable rates of morbidity and mortality. Despite the presence of...

    Jamshed Dalal, Praveen Chandra, ... Panchanan Sahoo in Cardiology and Therapy
    Article Open access 29 June 2023
  14. Diuretic and renal effects of angiotensin receptor-neprilysin inhibitor in patients hospitalized for acute heart failure

    In patients hospitalized for acute decompensation of heart failure (HF), the impact of angiotensin receptor-neprilysin inhibitor (ARNI) on diuresis...

    Naoto Setoguchi, Yu Horiuchi, ... Kengo Tanabe in Heart and Vessels
    Article 01 March 2023
  15. The (pro)renin receptor as a pharmacological target in cardiorenal diseases

    The (pro)renin receptor ((P)RR) is not only a member of the renin-angiotensin system (RAS) but also exerts several RAS-independent functions due to...

    Heiko Funke-Kaiser, Thomas Unger in Hypertension Research
    Article 04 September 2023
  16. Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians

    Renin angiotensin system (RAS) alters various mechanisms related to muscle wasting. The RAS system consists of classical and non-classical pathways,...

    Baris Afsar, Rengin Elsurer Afsar, ... John C. Edwards in Molecular and Cellular Biochemistry
    Article Open access 29 May 2024
  17. Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis

    This study comprehensively investigated clinical outcomes associated with renin angiotensin system inhibitor-based dual antihypertensive regimens in...

    Miseung Cho, Chang-Young Choi, ... Sandy Jeong Rhie in Scientific Reports
    Article Open access 07 April 2023
  18. Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

    Background

    To investigate the effects of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blockers (ARBs) administration to...

    Wenjun Wang, **aohui Zhao, ... ****g Zhuang in BMC Infectious Diseases
    Article Open access 25 January 2021
  19. Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

    Background and aims

    Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i)...

    Ming-Lung Tsai, Yuan Lin, ... Tien-Hsing Chen in Diabetology & Metabolic Syndrome
    Article Open access 26 May 2023
  20. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

    The role of autoimmunity in neurodegeneration has been increasingly suggested. The renin-angiotensin system (RAS) autoantibodies play a major role in...

    Carmen M. Labandeira, Maria A. Pedrosa, ... Jose L. Labandeira-Garcia in npj Parkinson's Disease
    Article Open access 14 June 2022
Did you find what you were looking for? Share feedback.